摘要
为探讨乳果糖口服液联合枯草杆菌二联活菌治疗小儿功能性便秘的效果,将60例功能性便秘患儿随机分为观察组和对照组,各30例。观察组采用乳果糖口服液联合枯草杆菌二联活菌颗粒口服治疗,对照组单纯采用乳果糖口服液口服。观察比较两组临床疗效,大便性状及复发情况。结果显示,观察组总有效率高于对照组(P<0.05);大便性状评分高于对照组(P<0.05);停药3、6个月后观察组复发率低于对照组(P<0.05)。结果表明,功能性便秘患儿使用乳果糖口服液联合枯草杆菌二联活菌治疗,可有效提高疗效,改善大便性状,减少复发。
This study was to investigate the effect of lactulose oral liquid combined with Bacillus subtilis bigeminy(live)in the treatment of infantile functional constipation(IFC),randomly divided 60IFC pediatric patients into observation group(30cases,received above combination medication)and control group(30cases,alone lactubse oral liquid);then,compared both groups'clinical effect,fecal form and recurrence status.As results,in total effective rate,in fecal form's score rating,and the recurrence rate at 3,6months after withdrawal of drugs observation group was significantly and respectively higher,higher,and lower than control group(all,P<0.05).Results show that the combination medication for IFC can effectively uplift effect,improve fecal forms,and reduce recurrence.
作者
汪军
WANG Jun(Dept.of Pediatry,the People's Hospital of Shandan County,Zhangye,Gansu 734100)
出处
《中国肛肠病杂志》
2020年第12期48-50,共3页
Chinese Journal of Coloproctology
关键词
小儿功能性便秘
乳果糖口服液
枯草杆菌二联活菌
Infantile functional constipation
Lactulose oral liquid
Bacillus subtilis bigeminy(live)
